(Q36554610)
Statements
One-year efficacy and safety of a fixed combination of insulin degludec and liraglutide in patients with type 2 diabetes: results of a 26-week extension to a 26-week main trial (English)
S C L Gough
B W Bode
V C Woo
H W Rodbard
S Linjawi
M Zacho